Bessemer Group Inc Catalent, Inc. Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 1,557 shares of CTLT stock, worth $94,945. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,557

Previous 1,320 17.95%

Holding current value

$94,945

Previous $74,000 28.38%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$56.16 - $60.96 $13,309 - $14,447	237 Added 17.95%	1,557 $95,000
Q2 2024 Aug 13, 2024	BUY	$53.58 - $57.02 $11,412 - $12,145	213 Added 19.24%	1,320 $74,000
Q1 2024 May 13, 2024	SELL	$42.56 - $59.82 $162,749 - $228,751	-3,824 Reduced 77.55%	1,107 $62,000
Q4 2023 Feb 09, 2024	SELL	$32.18 - $46.57 $93,740 - $135,658	-2,913 Reduced 37.14%	4,931 $221,000
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $46,100 - $52,358	1,043 Added 15.34%	7,844 $358,000
Q2 2023 Aug 10, 2023	BUY	$31.86 - $67.26 $8,028 - $16,949	252 Added 3.85%	6,801 $295,000
Q1 2023 May 10, 2023	BUY	$45.44 - $74.26 $18,266 - $29,852	402 Added 6.54%	6,549 $429,000
Q4 2022 Feb 13, 2023	SELL	$41.39 - $81.0 $68.1 Million - $133 Million	-1,645,246 Reduced 99.63%	6,147 $277,000
Q3 2022 Nov 09, 2022	SELL	$72.36 - $113.1 $1.26 Million - $1.98 Million	-17,467 Reduced 1.05%	1,651,393 $119 Million
Q2 2022 Aug 10, 2022	BUY	$87.2 - $114.05 $29.4 Million - $38.5 Million	337,506 Added 25.35%	1,668,860 $179 Million
Q1 2022 May 12, 2022	BUY	$94.19 - $124.49 $1.74 Million - $2.3 Million	18,512 Added 1.41%	1,331,354 $148 Million
Q4 2021 Jan 27, 2022	BUY	$119.57 - $139.07 $1.77 Million - $2.05 Million	14,767 Added 1.14%	1,312,842 $168 Million
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $1.67 Million - $2.18 Million	15,294 Added 1.19%	1,298,075 $173 Million
Q2 2021 Aug 06, 2021	BUY	$100.34 - $115.69 $317,275 - $365,811	3,162 Added 0.25%	1,282,781 $139 Million
Q1 2021 May 13, 2021	BUY	$101.51 - $125.27 $130 Million - $160 Million	1,278,953 Added 192034.98%	1,279,619 $135 Million
Q4 2020 Feb 09, 2021	BUY	$85.88 - $105.36 $34,180 - $41,933	398 Added 148.51%	666 $70,000
Q2 2020 Aug 05, 2020	BUY	$48.02 - $79.04 $12,869 - $21,182	268 New	268 $20,000
Q1 2019 May 13, 2019	SELL	$29.84 - $43.92 $798,757 - $1.18 Million	-26,768 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$29.95 - $46.34 $139,806 - $216,315	4,668 Added 21.12%	26,768 $834,000
Q1 2018 May 10, 2018	BUY	$39.4 - $47.39 $145,780 - $175,343	3,700 Added 20.11%	22,100 $907,000
Q3 2017 Nov 03, 2017	BUY	$33.75 - $41.67 $621,000 - $766,728	18,400	18,400 $735,000

Others Institutions Holding CTLT

# of Institutions

513

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Catalent, Inc. Transaction History